Inventor
SIEVERS ERIC
US16 patents
⚠️ This page may combine multiple inventors who share the name “SIEVERS ERIC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEATTLE GENETICS INC
5 patentsUS10098963B2Oct 16, 2018
Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates
SEATTLE GENETICS INC10 citations92
US9713648B2Jul 25, 2017
Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates
SEATTLE GENETICS INC11 citations92
US7695716B2Apr 13, 2010
Methods of treating neoplastic, autoimmune and inflammatory diseases
SEATTLE GENETICS INC75 citations92
US10722549B2Jul 28, 2020
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates
SEATTLE GENETICS INC7 citations83
US10478469B2Nov 19, 2019
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates
SEATTLE GENETICS INC6 citations83
SEAGEN INC
5 patentsUS11077164B2Aug 3, 2021
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates
SEAGEN INC3 citations83
US10940178B2Mar 9, 2021
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates
SEAGEN INC4 citations83
US10912813B2Feb 9, 2021
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates
SEAGEN INC5 citations83
US11369658B2Jun 28, 2022
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates
SEAGEN INC2 citations72
US11559558B2Jan 24, 2023
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates
SEAGEN INC0 citations62